Equity securities

CIM Commercial Trust Announces Tender Offer to Purchase up to 2,693,580 Shares of Series L Preferred Stock

Retrieved on: 
Tuesday, October 22, 2019

The Tender Offer is not conditioned upon any minimum or maximum number of shares being tendered, but is subject to certain other conditions as described in the Offer to Purchase.

Key Points: 
  • The Tender Offer is not conditioned upon any minimum or maximum number of shares being tendered, but is subject to certain other conditions as described in the Offer to Purchase.
  • Shareholders must make their own determination as to whether to tender their shares in the Tender Offer and, if so, the number of such shares to tender.
  • The Tender Offer is intended only to be available to holders of Series L preferred stock within the United States and Israel, and we are not aware of shareholders of Series L preferred stock in any other jurisdiction.
  • Holders of Series L Preferred Stock are encouraged to assess their own multiple on invested capital prior to deciding whether and to what extent to tender their shares of Series L Preferred Stock.

Citi Appointed as Depositary Bank for Innate Pharma’s ADR Programme

Retrieved on: 
Tuesday, October 22, 2019

Citi, acting through Citibank N.A., has been appointed by Innate Pharma S.A a commercial stage oncology-focused biotech company to act as depositary bank for its American Depositary Receipt (ADR) programme.

Key Points: 
  • Citi, acting through Citibank N.A., has been appointed by Innate Pharma S.A a commercial stage oncology-focused biotech company to act as depositary bank for its American Depositary Receipt (ADR) programme.
  • Innate Pharmas American Depositary Shares (ADS) trade on the Nasdaq Global Select Market under the symbol IPHA.
  • Innate Pharmas underlying ordinary shares are listed and trade on Euronext Paris under the symbol IPH.'
  • Innate Pharmas broad pipeline of antibodies includes several potentially first-in-class clinical and preclinical candidates in cancers with high unmet medical need.

SITE Centers Announces Pricing of Common Shares Offering

Retrieved on: 
Tuesday, October 22, 2019

SITE Centers Corp. (NYSE: SITC) (SITE Centers or the Company) today announced the pricing of its public offering of 11,500,000 common shares at a price to public of $14.90 per share, for expected gross proceeds of approximately $171.4 million.

Key Points: 
  • SITE Centers Corp. (NYSE: SITC) (SITE Centers or the Company) today announced the pricing of its public offering of 11,500,000 common shares at a price to public of $14.90 per share, for expected gross proceeds of approximately $171.4 million.
  • SITE Centers also granted the underwriters a 30-day option to purchase up to an additional 1,725,000 common shares.
  • SITE Centers intends to use the net proceeds of the offering to redeem a portion of the depositary shares representing its outstanding 6.50% Class J Cumulative Redeemable Preferred Shares, without par value (the Class J Preferred Shares), which have an aggregate liquidation preference of $200.0 million.
  • This release does not constitute a notice of redemption of the depositary shares representing the Class J Preferred Shares.

Glancy Prongay & Murray LLP Continues Its Investigation on Behalf of Tandy Leather Factory, Inc. Investors

Retrieved on: 
Monday, October 21, 2019

Glancy Prongay & Murray LLP (GPM) continues its investigation on behalf of Tandy Leather Factory, Inc. (Tandy or the Company) (NASDAQ: TLF ) investors concerning the Company and its officers possible violations of federal securities laws.

Key Points: 
  • Glancy Prongay & Murray LLP (GPM) continues its investigation on behalf of Tandy Leather Factory, Inc. (Tandy or the Company) (NASDAQ: TLF ) investors concerning the Company and its officers possible violations of federal securities laws.
  • If you are a shareholder who suffered a loss, click here to participate.
  • If you inquire by email please include your mailing address, telephone number and number of shares purchased.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Veritex Holdings, Inc. Declares Cash Dividend on Common Stock

Retrieved on: 
Monday, October 21, 2019

DALLAS, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Veritex Holdings, Inc. (Nasdaq: VBTX) (Veritex or the Company), the parent holding company for Veritex Community Bank, today announced the declaration of a quarterly cash dividend of $0.125 per share on its outstanding common stock.

Key Points: 
  • DALLAS, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Veritex Holdings, Inc. (Nasdaq: VBTX) (Veritex or the Company), the parent holding company for Veritex Community Bank, today announced the declaration of a quarterly cash dividend of $0.125 per share on its outstanding common stock.
  • The dividend will be paid on or after November 21, 2019 to stockholders of record as of the close of business on November 7, 2019.
  • Headquartered in Dallas, Texas, Veritex is a bank holding company that conducts banking activities through its wholly-owned subsidiary, Veritex Community Bank, with locations throughout the Dallas-Fort Worth metroplex and in the Houston metropolitan area.
  • The forward-looking statements include statements regarding Veritex's projected plans and objectives, including the expected payment date of its common stock dividend.

Citizens Financial Group Announces Pricing of $450 Million Preferred Stock Depositary Shares Offering

Retrieved on: 
Monday, October 21, 2019

Citizens Financial Group, Inc. (NYSE: CFG) today announced the pricing of an offering of 18,000,000 depositary shares each representing a 1/40th interest in a share of its 5.000% fixed-rate non-cumulative perpetual Series E Preferred Stock, liquidation preference $1,000 per share (equivalent to $25 per depositary share) at an aggregate offering price of $450 million.

Key Points: 
  • Citizens Financial Group, Inc. (NYSE: CFG) today announced the pricing of an offering of 18,000,000 depositary shares each representing a 1/40th interest in a share of its 5.000% fixed-rate non-cumulative perpetual Series E Preferred Stock, liquidation preference $1,000 per share (equivalent to $25 per depositary share) at an aggregate offering price of $450 million.
  • The offering is expected to close on October 28, 2019, subject to customary closing conditions.
  • The offering is being made pursuant to an effective shelf registration statement, including a prospectus, filed by CFG with the U.S. Securities and Exchange Commission (SEC).
  • Citizens Financial Group, Inc. is one of the nations oldest and largest financial institutions, with $164.4 billion in assets as of September 30, 2019.

SITE Centers Announces Offering of Common Shares

Retrieved on: 
Monday, October 21, 2019

SITE Centers Corp. (NYSE: SITC) (SITE Centers or the Company) today announced the commencement of a public offering of 10,500,000 common shares.

Key Points: 
  • SITE Centers Corp. (NYSE: SITC) (SITE Centers or the Company) today announced the commencement of a public offering of 10,500,000 common shares.
  • SITE Centers also expects to grant the underwriters a 30-day option to purchase up to an additional 1,575,000 common shares.
  • SITE Centers intends to use the net proceeds of the offering to redeem a portion of the depositary shares representing its outstanding 6.50% Class J Cumulative Redeemable Preferred Shares, without par value (the Class J Preferred Shares), which have an aggregate liquidation preference of $200.0 million.
  • SITE Centers is an owner and manager of open-air shopping centers that provide a highly-compelling shopping experience and merchandise mix for retail partners and consumers.

Kingold Jewelry Announces 1:6 Reverse Stock Split of Common Stock

Retrieved on: 
Monday, October 21, 2019

WUHAN CITY, China, Oct. 21, 2019 /PRNewswire/ -- Kingold Jewelry, Inc. ("Kingold" or the "Company") (NASDAQ: KGJI), one of China's leading manufacturers and designers of high quality 24-karat gold jewelry, ornaments and investment-oriented products, today announced, the Board of Directors and a majority of the shareholders of Kingold, approved on September 26, 2019 and October 7, 2019, respectively, a 1-for-6 reverse stock split of the Company's issued and outstanding shares of common stock (the "Reverse Stock Split").

Key Points: 
  • WUHAN CITY, China, Oct. 21, 2019 /PRNewswire/ -- Kingold Jewelry, Inc. ("Kingold" or the "Company") (NASDAQ: KGJI), one of China's leading manufacturers and designers of high quality 24-karat gold jewelry, ornaments and investment-oriented products, today announced, the Board of Directors and a majority of the shareholders of Kingold, approved on September 26, 2019 and October 7, 2019, respectively, a 1-for-6 reverse stock split of the Company's issued and outstanding shares of common stock (the "Reverse Stock Split").
  • As of October 21, 2019 (immediately prior to the Effective Date), there were 66,113,502 shares of common stock outstanding.
  • As a result of the Reverse Stock Split, there are approximately 11,018,917 shares of common stock outstanding (subject to adjustment due to the effect of rounding fractional shares into whole shares).
  • The Reverse Stock Split will not have any effect on the stated par value of the common stock.

Leading Private Equity Partner Scott Abramowitz Joins Ropes & Gray in New York

Retrieved on: 
Monday, October 21, 2019

NEW YORK, Oct. 21, 2019 /PRNewswire/ -- Global law firm Ropes & Gray today announced that Scott A. Abramowitz has joined the firm as a partner in its 350-lawyer New York office.

Key Points: 
  • NEW YORK, Oct. 21, 2019 /PRNewswire/ -- Global law firm Ropes & Gray today announced that Scott A. Abramowitz has joined the firm as a partner in its 350-lawyer New York office.
  • Mr. Abramowitz expands Ropes & Gray's preeminent private equity practice, which represents clients in both multibillion-dollar and middle-market deals around the globe.
  • "Ropes & Gray is the top firm for private equity investors who are seeking creative, strategic and thoughtful guidance," said Mr. Abramowitz.
  • Ropes & Gray has been at the forefront of private equity law and remains active in both multi-billion-dollar and middle-market deals.

Bionano Genomics Announces Pricing of $18 Million Underwritten Public Offering

Retrieved on: 
Monday, October 21, 2019

For each pre-funded warrant Bionano sells, the number of shares of common stock Bionano is offering will be decreased on a one-for-one basis.

Key Points: 
  • For each pre-funded warrant Bionano sells, the number of shares of common stock Bionano is offering will be decreased on a one-for-one basis.
  • The offering is expected to close on or aboutOctober 23, 2019, subject to customary closing conditions.
  • The gross proceeds to Bionano from this offering are expected to be approximately$18 million, before deducting underwriting discounts and commissions and other offering expenses payable by Bionano, and excluding any proceeds that may be received upon exercise of the common warrants.
  • Such forward-looking statements include, without limitation, statements about Bionanos expectations regarding the completion, timing and size of the public offering and the anticipated use of net proceeds therefrom.